Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab

Author:

Ghia Paolo1,Barnes Gisoo2,Yang Keri2,Tam Constantine S.34,Robak Tadeusz5,Brown Jennifer R.6ORCID,Kahl Brad S.7,Tian Tian2,Szeto Andy2,Paik Jason C.2,Shadman Mazyar89

Affiliation:

1. Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

2. Health Economics and Outcomes Research, BeiGene USA, Inc, San Mateo, CA, USA

3. The Alfred Hospital, Melbourne, VIC, Australia

4. Monash University, Clayton, VIC, Australia

5. Department of Hematology, Medical University of Lodz, Lodz, Poland

6. Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

7. Department of Medicine, Washington University School of Medicine, St Louis, MO, USA

8. Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA

9. Department of Medicine, University of Washington, Seattle, WA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Reference28 articles.

1. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019

2. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. National Cancer Institute. SEER Cancer Stat Facts: chronic lymphocytic leukemia/small lymphocytic lymphoma. [cited 2023 Jun 25]. Available from: https://seer.cancer.gov/statfacts/html/cllsll.html

4. Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents

5. American Cancer Society. Signs and symptoms of chronic lymphocytic leukemia. [cited 2023 Jun 25]. Available from: https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/detection-diagnosis-staging/signs-symptoms.html

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3